Ayala Pharmaceuticals Inc (ADXS)

[bill_y]

there are only 40 million shares outstanding..a phenomenally low number for a baby bio ..10 million of those 40 million are owed to lenders by shorts. the tech is stellar being pursued by GOG as new SOC for hpv..and as a targeting system for other treatments..900 million in future revenue already..no volume..waiting on the inevitable with buyers just nibbling around the edges..doc is gone so earlier monitization makes dilution much less likely..and all sorts of news is imminent ..just off the top of my head..there is much more..and all this unfolding likely between now and end of year..